{"id":724793,"date":"2023-01-20T13:34:57","date_gmt":"2023-01-20T18:34:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/"},"modified":"2023-01-20T13:34:57","modified_gmt":"2023-01-20T18:34:57","slug":"paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/","title":{"rendered":"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Presentation on Thursday, January 26th, 2023 at 1:30 PM EST<\/em>\n      <\/p>\n<p align=\"center\">\n        \n      <\/p>\n<p align=\"start\">TARRYTOWN, NY, Jan.  20, 2023  (GLOBE NEWSWIRE) &#8212; via\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pCqHXYTlKtS9KLP1cd62H0z5BTfMlenxZw8sAJcROYA_g_C2OcOlbOa2ri4HnpsIKYs6vHcx3j79uDU7H1kWhg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>NewMediaWire<\/u><\/a>\u00a0&#8212;\u00a0PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (\u201cAPT\u201d) for the treatment of disorders with intractable neurologic symptoms, today announced that it will be presenting virtually at the upcoming\u00a0Virtual Investor Summit on January 26<sup>th<\/sup>.\u00a0<\/p>\n<p align=\"start\">\n        <strong>Event:<\/strong>\u00a0\u00a0\u00a0Q1 Investor Summit<\/p>\n<p align=\"start\">\n        <strong>Date:<\/strong>\u00a0\u00a0\u00a0Thursday, January 26th, 202<strong>3<\/strong><\/p>\n<p align=\"start\">\n        <strong>Presentation:<\/strong>\u00a0\u00a0\u00a0January 26th\u00a0at 1:30 PM ET\u00a0<\/p>\n<p align=\"start\">\n        <strong>Location: \u00a0<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hag-pWLa0JOlV1XBPp9gUDzQkjrMkGUaoRe_Vvq72RT1ioR-dxutd7e8kQlLJTFtoI18jNuzQms5_Dfw3gkFe9FD1m3pFW_Vkwn-NskiZBdydGM1eHdqj6CWWF0tyMpbi821xX-h-H8P7ADQm3o-6t830ZH7mu-P5Ikk7p4L1NRHY5rS_hIAvNIrggbZElKKg6-d3ZVDkl4J5XCFOTCeLw==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>https:\/\/us06web.zoom.us\/webinar\/register\/WN_LRZ8iM38TTCNpbbgvkUvCA<\/u><br \/>\n        <\/a>\u00a0<\/p>\n<ul>\n<li>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The theme is 25 micro-cap companies with a catalyst and\/or strong performance in the current market<\/li>\n<li>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01x1s will be available for qualified investors<\/li>\n<li>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The conference is completely complimentary to qualified investors. Please register at\u00a0<a href=\"https:\/\/www.meetmax.com\/sched\/event_92251\/investor_reg_new.html?attendee_role_id=ISG_INVESTOR\" rel=\"nofollow noopener\" target=\"_blank\"><u>Complimentary Investor Registration<\/u><\/a><\/li>\n<\/ul>\n<p align=\"justify\">\n        <b>About PaxMedica<\/b>\n      <\/p>\n<p align=\"justify\">PaxMedica is a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (\u201cAPT\u201d) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including Autism Spectrum Disorder (\u201cASD\u201d), to Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (\u201cME\/CFS\u201d), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (\u201cCOVID-19\u201d). One of PaxMedica\u2019s primary points of focus is the development and testing of its lead program, PAX-101, an intravenous formulation of suramin, in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders such as ME\/CFS and Long COVID-19 Syndrome, a clinical diagnosis in individuals who have been previously infected with COVID-19. For more information, please visit: www.paxmedica.com<\/p>\n<p align=\"start\">\n        <b>About the Investor Summit<\/b>\n      <\/p>\n<p align=\"start\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qxUJjADWEecO1xELlC-iintONZvK5dElVRcxGfX_cNF3jQQK-t94puoxnN2H0J72-s2freGzcGF9xe-Opym7N7Gm0SFGA8tlqo2K2OQLZKFCnPJlnJ85A3qVscFMmEk5\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>The Investor Summit<\/u><br \/>\n        <\/a>\u00a0is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 30 companies and over 120 institutional, family office, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Technology, Financial, Healthcare, Industrials, Materials, Real Estate. Contact:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g3SPj0RIcpAI0-rW_ufI3g8MMwina1KTcPd5RvIzWZY19ueBYKme6Q8Kg0csPD6SIweFBw0tU8rm10q-xr2Jj1oXboecg8Nj_WJwxx9sHBYC9OdqemSr-xhyHU8elu2a\" rel=\"nofollow noopener\" target=\"_blank\"><u>emily@investorsummitgroup.com<\/u><\/a><\/p>\n<p align=\"start\">\n        <b>Contacts:<\/b>\n      <\/p>\n<p align=\"start\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aLfOIgLv1yrjxdgbh1adt91p7aRP4RGTsvPMzBHLqieYgSVFpHyy4uHoRRAQsQ7S91jiQLqBnvuDFU8ql0vb_J5Qnrtoht7i4oO3vjLnD8VoOZVY2j9-2CrTdKDNvH-mba2dDqD03DwexWz77pX06Q4-p6D5ndMUsiTS980m6wVdqIlXmuoxYuNKcs2QQIBjQGWxEBB8WrRvyUFHE_75auSSJRkditCxlRD6OCmiaqs=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>ir@paxmedica.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p align=\"start\">Stephanie Prince<br \/>PCG Advisory<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-RFfeB56l36wisApIMMMWjElY3QcSK4qRfOFVxxApKICYs2QyNIcdllTaHbvYiQ6Chrz2ujPQLr50DjBndeO4SKTw83SIq2gdk4LLVZ9nW0Sw0Lh8lhfadX4p1i3bRrmc7nBX2uhQ5vByCXTz-xIHKPcYm4ni1Yj6VBziaZHB94cLeNwcCwDZfDiUMDAZmxcYyPVDPiqw9UStjuUfjrAwWwX5iVwqGpTBl4TGMt7XM1S1jl5UYJ2IM3hprrxXqIwgXVzLF1Cxpopx8be1P1img==\" rel=\"nofollow noopener\" target=\"_blank\"><u>sprince@pcgadvisory.com<\/u><\/a><br \/>(646) 863-6341<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWRlYmVjZDMtYjE4Zi00ZTY1LWI4YTMtODU1MTNkOTQxYjQ4LTUwMDA3NzQ3NA==\/tiny\/PaxMedica-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Presentation on Thursday, January 26th, 2023 at 1:30 PM EST TARRYTOWN, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) &#8212; via\u00a0NewMediaWire\u00a0&#8212;\u00a0PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (\u201cAPT\u201d) for the treatment of disorders with intractable neurologic symptoms, today announced that it will be presenting virtually at the upcoming\u00a0Virtual Investor Summit on January 26th.\u00a0 Event:\u00a0\u00a0\u00a0Q1 Investor Summit Date:\u00a0\u00a0\u00a0Thursday, January 26th, 2023 Presentation:\u00a0\u00a0\u00a0January 26th\u00a0at 1:30 PM ET\u00a0 Location: \u00a0 https:\/\/us06web.zoom.us\/webinar\/register\/WN_LRZ8iM38TTCNpbbgvkUvCA \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The theme is 25 micro-cap companies with a catalyst and\/or strong performance in the current market \u00a0\u00a0\u00a0\u00a0\u00a0\u00a01x1s will be available for qualified investors \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The conference is completely complimentary to qualified investors. Please register at\u00a0Complimentary Investor Registration About PaxMedica PaxMedica is a clinical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-724793","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Presentation on Thursday, January 26th, 2023 at 1:30 PM EST TARRYTOWN, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) &#8212; via\u00a0NewMediaWire\u00a0&#8212;\u00a0PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (\u201cAPT\u201d) for the treatment of disorders with intractable neurologic symptoms, today announced that it will be presenting virtually at the upcoming\u00a0Virtual Investor Summit on January 26th.\u00a0 Event:\u00a0\u00a0\u00a0Q1 Investor Summit Date:\u00a0\u00a0\u00a0Thursday, January 26th, 2023 Presentation:\u00a0\u00a0\u00a0January 26th\u00a0at 1:30 PM ET\u00a0 Location: \u00a0 https:\/\/us06web.zoom.us\/webinar\/register\/WN_LRZ8iM38TTCNpbbgvkUvCA \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The theme is 25 micro-cap companies with a catalyst and\/or strong performance in the current market \u00a0\u00a0\u00a0\u00a0\u00a0\u00a01x1s will be available for qualified investors \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The conference is completely complimentary to qualified investors. Please register at\u00a0Complimentary Investor Registration About PaxMedica PaxMedica is a clinical &hellip; Continue reading &quot;PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-20T18:34:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event\",\"datePublished\":\"2023-01-20T18:34:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/\"},\"wordCount\":350,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/\",\"name\":\"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==\",\"datePublished\":\"2023-01-20T18:34:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/","og_locale":"en_US","og_type":"article","og_title":"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event - Market Newsdesk","og_description":"Presentation on Thursday, January 26th, 2023 at 1:30 PM EST TARRYTOWN, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) &#8212; via\u00a0NewMediaWire\u00a0&#8212;\u00a0PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (\u201cAPT\u201d) for the treatment of disorders with intractable neurologic symptoms, today announced that it will be presenting virtually at the upcoming\u00a0Virtual Investor Summit on January 26th.\u00a0 Event:\u00a0\u00a0\u00a0Q1 Investor Summit Date:\u00a0\u00a0\u00a0Thursday, January 26th, 2023 Presentation:\u00a0\u00a0\u00a0January 26th\u00a0at 1:30 PM ET\u00a0 Location: \u00a0 https:\/\/us06web.zoom.us\/webinar\/register\/WN_LRZ8iM38TTCNpbbgvkUvCA \u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The theme is 25 micro-cap companies with a catalyst and\/or strong performance in the current market \u00a0\u00a0\u00a0\u00a0\u00a0\u00a01x1s will be available for qualified investors \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The conference is completely complimentary to qualified investors. Please register at\u00a0Complimentary Investor Registration About PaxMedica PaxMedica is a clinical &hellip; Continue reading \"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-20T18:34:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event","datePublished":"2023-01-20T18:34:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/"},"wordCount":350,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/","name":"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==","datePublished":"2023-01-20T18:34:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczMzY3NCM1MzY2NTc0IzUwMDA3NzQ3NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paxmedica-to-present-at-the-jan-26th-virtual-investor-summit-microcap-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PaxMedica to\u00a0Present at the Jan 26th Virtual Investor Summit Microcap Event"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/724793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=724793"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/724793\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=724793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=724793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=724793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}